Quantcast

Latest Antipsychotic Stories

2014-08-16 23:02:22

The Firm is representing numerous clients in Risperdal lawsuits that allege gynecomastia, or male breast development, due to their use of the antipsychotic drug. New York, NY (PRWEB) August 16, 2014 A Risperdal (http://www.lawreward.com/risperdal/) meeting is scheduled to take place next month in the Philadelphia Court of Common Pleas, where hundreds of lawsuits over the antipsychotic medication are continuing to move forward, Bernstein Liebhard LLP reports. According to a Calendar...

Schizophrenia drug dimmer switch
2014-08-16 06:15:32

Rayshell Clapper for redOrbit.com - Your Universe Online Schizophrenia affects about one percent of the world’s population and, if untreated, leaves sufferers struggling with their relationships, jobs, and lives as a whole. According to the National Institute of Mental Illnesses, schizophrenia is a debilitating brain disorder whereby those diagnosed with this mental illness “may hear voices other people don't hear. They may believe other people are reading their minds, controlling...

2014-08-15 04:21:11

Lawsuit Help Center reports 2013 Johnson & Johnson settlement of $2.2 billion with U.S. Justice Dept. has caused cases to pile up. PHILADELPHIA, Aug. 15, 2014 /PRNewswire/ -- MT Services LLC, A Lawsuit Settlement News Reporting Company, which operates a lawsuit help center: lawsuitsettlementnews.com, announced today that there is ongoing litigation for victims of the antipsychotic drug Risperdal. The lawsuits claim that J&J failed to inform patients about potential harmful side...

2014-08-14 12:27:26

Ameritox's Ingenuity Health introduces method to help assess medication adherence in patients prescribed Seroquel XR BALTIMORE, Aug. 14, 2014 /PRNewswire/ -- Ameritox(SM), the nation's leader in medication monitoring solutions, today launched a method to help assess medication adherence in behavioral health patients prescribed the antipsychotic drug Seroquel XR, one of the 40 best-selling medications in the U.S. This new method marks a critical step toward building a comprehensive...

2014-08-14 08:30:05

First Patient Dosed in the EU Post-Authorization Safety Study MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its European Medicines Agency (EMA) post-approval studies for ADASUVE(®) inhalation powder, pre-dispensed (loxapine). As part of the ADASUVE approval process with the EMA, Alexza is required to conduct five post-approval studies: -- a benzodiazepine interaction study - study completed and data...

2014-08-09 23:03:20

Risperdal Lawsuit Claims Continue to Be Filed Against Johnson & Johnson Contending Male Breast Growth Due to the Manufacturer’s Antipsychotic Drug Risperdal Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 09, 2014 Risperdal lawsuits currently pending litigation in the Philadelphia Court of Common Pleas in Pennsylvania have grown to 662 Risperdal lawsuit claims filed against the makers of the antipsychotic drug, notes Wright & Schulte LLC. According to the court...

2014-08-08 23:01:07

The Firm is representing Risperdal lawsuit clients who allegedly developed gynecomastia, or male breast growth, due to the use of the antipsychotic medication. New York, New York (PRWEB) August 08, 2014 As Risperdal lawsuits (http://www.lawreward.com/risperdal/) mount in U.S. courts, Bernstein Liebhard LLP notes that yet another group of researchers has found data to support a link between exposure to risperidone, the active ingredient in the atypical antipsychotic drug, and the...

2014-08-08 08:26:35

First ADASUVE Launch in Latin America MOUNTAIN VIEW, Calif., Aug. 8, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE(®) inhalation powder, pre-dispensed (loxapine) is now available in Guatemala. This approval represents the first ADASUVE approval in Latin America for Ferrer and Alexza. Ferrer is Alexza's commercial partner for ADASUVE in the EU, Latin America and Commonwealth of Independent States countries. Ferrer introduced ADASUVE during a...

2014-08-02 23:01:40

The Firm is representing a number of Risperdal lawsuit clients who allegedly developed gynecomastia, or male breast growth, due to their use of the atypical antipsychotic drug. New York, New York (PRWEB) August 02, 2014 Risperdal lawsuits (http://www.lawreward.com/risperdal-lawsuit/) that allege use of the antipsychotic medication caused men and boys to develop gynecomastia, or male breast growth, continue to mount in U.S. courts, Bernstein Liebhard LLP reports. According to court...

2014-07-30 08:32:46

WOODCLIFF LAKE, N.J. and SAN DIEGO, July 30, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise as a Predictor of Week 52 Weight-Loss Outcomes," was recently published in the online issue of Obesity, the official peer reviewed journal of The Obesity Society. The objective of these...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'